Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,734,474
  • Shares Outstanding, K 86,364
  • Annual Sales, $ 37,310 K
  • Annual Income, $ -366,250 K
  • EBIT $ -474 M
  • EBITDA $ -455 M
  • 60-Month Beta 1.82
  • Price/Sales 118.48
  • Price/Cash Flow N/A
  • Price/Book 2.42

Options Overview Details

View History
  • Implied Volatility 61.59% ( +1.84%)
  • Historical Volatility 45.73%
  • IV Percentile 68%
  • IV Rank 44.67%
  • IV High 81.49% on 04/08/25
  • IV Low 45.53% on 08/26/24
  • Put/Call Vol Ratio 0.25
  • Today's Volume 28,413
  • Volume Avg (30-Day) 13,342
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 149,997
  • Open Int (30-Day) 130,833

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -1.54
  • Number of Estimates 11
  • High Estimate -0.93
  • Low Estimate -2.27
  • Prior Year -1.49
  • Growth Rate Est. (year over year) -3.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.81 +50.92%
on 06/12/25
60.13 -0.08%
on 07/09/25
+17.99 (+42.74%)
since 06/09/25
3-Month
32.90 +82.61%
on 04/10/25
60.13 -0.08%
on 07/09/25
+25.19 (+72.20%)
since 04/09/25
52-Week
30.04 +100.00%
on 04/07/25
63.68 -5.65%
on 07/16/24
+5.05 (+9.18%)
since 07/09/24

Most Recent Stories

More News
Innovation ETF (ARKK) Hits New 52-Week High

For investors seeking momentum, ARK Innovation ETF ARKK is probably on the radar. The fund just hit a 52-week high and is up about 92.4% from its 52-week low price of $36.85/share. But are more gains...

BEAM : 21.46 (+5.71%)
ROKU : 88.63 (+0.56%)
CRSP : 60.08 (+9.60%)
MASS : 7.07 (+3.82%)
ARKK : 72.37 (+2.07%)
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END

CLDI : 0.7000 (+108.96%)
CRSP : 60.08 (+9.60%)
CTMX : 2.49 (+3.75%)
VRTX : 478.96 (+2.70%)
IBRX : 2.79 (+2.95%)
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

/CNW/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is...

CLDI : 0.7000 (+108.96%)
CRSP : 60.08 (+9.60%)
CTMX : 2.49 (+3.75%)
VRTX : 478.96 (+2.70%)
IBRX : 2.79 (+2.95%)
10 Monster Stocks to Hold for the Next 10 Years

Each of these 10 businesses offers a market-leading product or service within an industry that's set to explode.

SHOP : 114.32 (+1.64%)
ACHR : 10.45 (+0.77%)
CRSP : 60.08 (+9.60%)
NU : 13.64 (+0.37%)
AXON : 805.86 (+1.98%)
SMR : 35.46 (+1.08%)
SOFI : 20.22 (+1.35%)
RKLB : 39.14 (+1.03%)
IONQ : 45.56 (+1.31%)
UBER : 96.64 (-0.86%)
2 Beaten-Down Stocks With Massive Upside Potential

VKTX : 30.40 (+0.70%)
CRSP : 60.08 (+9.60%)
2 Growth Stocks to Buy Hand Over Fist in July

These companies are poised to produce fireworks for your portfolio over the coming years.

CRSP : 60.08 (+9.60%)
LLY : 786.92 (+1.19%)
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX : 30.40 (+0.70%)
CRSP : 60.08 (+9.60%)
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?

CRISPR Therapeutics CRSP is currently the only company in the world to have secured approval for a CRISPR-based gene therapy developed in partnership with Vertex Pharmaceuticals. Following the landmark...

BEAM : 21.46 (+5.71%)
CRSP : 60.08 (+9.60%)
NTLA : 12.13 (+9.08%)
The Best Stocks to Invest $1,000 in Right Now

Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to bear more fruit.

NVDA : 162.88 (+1.80%)
CRSP : 60.08 (+9.60%)
HD : 371.04 (+0.96%)
PANW : 206.06 (+1.01%)
NEE : 73.65 (+1.64%)
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

CRSP : 60.08 (+9.60%)
REGN : 552.58 (+0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.

See More

Key Turning Points

3rd Resistance Point 65.88
2nd Resistance Point 63.01
1st Resistance Point 61.54
Last Price 60.08
1st Support Level 57.20
2nd Support Level 54.33
3rd Support Level 52.86

See More

52-Week High 63.68
Last Price 60.08
Fibonacci 61.8% 50.83
Fibonacci 50% 46.86
Fibonacci 38.2% 42.89
52-Week Low 30.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar